Welcome to the Journal
Cardiology as a field of study has been gaining great significance with the increasing financial burden to the nations of the globe. Cardio vascular diseases are the number one reason for deaths globally. Interventional cardiology is a scholarly open access journal that offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field.
Since cardiovascular diseases can be prevented by addressing behavioural risk factors Interventional cardiology journal includes wide areas of studies in this field by including apical hypertrophic cardiomyopathy, coronary artery ectasia, fetal heart calcification, chronic arterial insufficiency, cardiovascular disease and its association with cancer, peri-arrest period, complications after heart surgery, early repolarization symptoms, coronary arteritis, inflammatory vascular disease, inflammatory cardiomyopathy, systolic pressure variation, left atrium enlargement, and ventricular septal defect (VSD).
The journal offers thoroughly reviewed original research as research articles, review articles, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to association of abiotrophia species with heart problem, heart and blood vessel disorders, myocardial infarction (heart attack), issues of cardiac arrest, stroke, techniques and procedure used in stent implantation, anticoagulant drugs (blood thinners), basic research in heart structure and functions and other medical conditions and associated treatments etc.
The journal also focuses on the latest therapeutic efforts such as application of cardiac progenitor cells, angioplasty, percutaneous coronary intervention (PCI) such as percutaneous transluminal coronary angioplasty (PTCA), and other stent implantation, anticoagulant drugs (blood thinners), therapy after open heart surgery, use of ventricular assist device.
Submit your manuscripts through tracking System: www.scholarscentral.org/submission/interventional-cardiology.html or directly accpted by Editorial Office at [email protected]
Interventional Cardiology is listed in the quality indexing sites such as Scopus, EMBASE/Excerpta Medica to increase visibility and discoverability.
h-index
Articles published in Interventional Cardiology have been cited by esteemed scholars and scientists all around the world. Interventional Cardiology has got h-index 13 , which means every article in Interventional Cardiology has got 13 average citations.
Recently Published Articles
Mini Review p. 468-471
Cholesterol crystal embolism as complication of percutaneous coronary intervention
Author(s): Kotaro Takahashi, Ayumi Omuro, Masanobu Ohya, Shunsuke Kubo,Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Kazushige Kadota
Percutaneous Coronary Intervention (PCI) has become common treatment of coronary artery disease especially for acute coronary syndrome nowadays, while several complications cannot be complet..
Review Article p. 472-480
Cardiovascular diseases as major extrahepatic manifestations of hepatitis C virus infection: Leukocytes, not hepatocytes, are the targets of hepatitis C virus infection
Author(s): Akira Matsumori
Almost all viruses cause cardiovascular diseases, and coxsackievirus and influenza virus are thought to be the most common causes of acute myocardial injuries. On the other hand, Hepatitis C..
Research Article p. 481-487
Association between serum high-density lipoprotein cholesterol concentration and mortality in critically ill patients: A retrospective cohort study
Author(s): Xu Guo, Zhiyu Xu, Hengxing Qu, Ryan Charles Woods, Eunice Njobvu, Zhongyi Zhou, Xiaohong Xie, Jia Tian
Objective: This research aims to explore the association between serum High-Density Lipoprotein Cholesterol (HDL-C) and mortality in critically ill patients. Design: This was a retrospect..
Review Article p. 488-496
Choice and timing of P2Y12 antiplatelet agents in non-STE acute coronary syndrome: A review
Author(s): Saba Assar, David Louis, J. Dawn Abbott
Acute coronary syndromes remain a leading cause of morbidity and mortality worldwide. Reducing both ischemic and bleeding complications after percutaneous coronary intervention remains of pa..
